保护公民,促进预防:在欧洲负责任使用食补充剂的框架
Arrigo F G Cicero1,2, Claudio Borghi1, Federica Fogacci1,3,4
1Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40100 Bologna, Italy.
Nutrients
|March 14, 2026
概括
欧盟委员会正在加大努力,保护整个生命的心血管健康. 该倡议旨在改善所有公民的长期心脏健康结果.
科学领域:
- 公共卫生 公共卫生
- 心脏病学 心脏病学
- 卫生政策 卫生政策
背景情况:
- 心血管疾病仍然是全球主要的死亡原因.
- 越来越多的人认为,一生的方法对于有效的预防策略至关重要.
- 现有的政策需要加强,以全面解决心血管健康问题.
研究的目的:
- 评估欧盟委员会对心血管健康的承诺.
- 概述政策制定和实施的关键领域.
- 倡导综合,基于生命历程的心血管健康保护.
主要方法:
- 欧盟委员会文件和倡议的政策分析.
- 关于终身心血管健康的科学文献的综述.
- 咨询利益相关者和综合专家意见.
主要成果:
- 欧盟委员会显示出对心血管健康保护的日益雄心勃勃.
- 需要具体的政策建议才能将雄心壮志转化为行动.
- 终身策略对于可持续的心血管健康改善至关重要.
结论:
- 欧盟委员会对终身心血管健康的关注是一个积极的发展.
- 持续的政治意愿和有针对性的政策是成功所必需的.
- 跨部门的合作对于减少心血管疾病的负担至关重要.
相关概念视频
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Proteins: Dietary Sources and Requirements
2.0K
Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
2.0K
Clinically Relevant Drug Product Specifications: Methods of Establishment
279
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
279
Lipids: Dietary Sources and Requirements
2.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Drug Control Governance: Regulatory Bodies and Their Impact
635
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
635
